United States · Series B startup

Who invested in Candesant Biomedical

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2023, from 1 source

Latest round
Series B, $35MJun 2023
Investors
2
See who backed them

The rounds

  1. Jun 2023
    Series B$35M

    Source recordedSEC filing: $35M sold, first sale Apr 2022

Founders and team

From the SEC filings it signed: 2 on the team.

  • Mary Beth L. KreisslerExecutive Officeri
  • Niquette L. HuntExecutive Officer, Directori

On the board, as filediBrad L. HauserEileen L. McGuireKaren L. LongMichael L. KaneSamara L. Braunstein

Everyone who backed them

Polaris PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Candesant Biomedical

Who invested in Candesant Biomedical?

Candesant Biomedical's investors include Polaris Partners and Correlation Ventures.

How much has Candesant Biomedical raised?

Candesant Biomedical has raised $35M across 1 round since 2023.

When did Candesant Biomedical last raise?

Candesant Biomedical's most recent round was a Series B of $35M in Jun 2023.

What was Candesant Biomedical's biggest round?

Its most recent round, $35M in Jun 2023, is also its largest on record.

Who backed Candesant Biomedical first?

Candesant Biomedical's first round on record, in Jun 2023, was backed by Polaris Partners and Correlation Ventures.

What stage is Candesant Biomedical at?

Candesant Biomedical's latest named round is a Series B, in Jun 2023.

Where is Candesant Biomedical based?

Candesant Biomedical is based in the United States.

Companies like Candesant Biomedical

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.